Arbor Vita Announces Presentations at International Papillomavirus Conference Sunnyvale, CAAugust 30, 2006Arbor Vita Corporation announced today that three abstracts featuring the company's drug discovery and preclinical development of its HPV diagnostic and therapeutic programs have been accepted f...

Home NewsArbor Vita in the NewsPress Area About UsContact UsTechnologyPublicationsManagementPolicies ProductsDiagnostics OncoE6 Cervical Test A/H5N1 Flu Test Careers Arbor Vita Announces OncoE6 Cervical Test Interim Study Results Arbor Vita has announced interim clinical study results...

Home NewsArbor Vita in the NewsPress Area About UsContact UsTechnologyPublicationsManagementPolicies ProductsDiagnostics OncoE6 Cervical Test A/H5N1 Flu Test Careers ManagementBoard of Directors About UsContact UsTechnologyPublicationsManagementPolicies Peter S. Lu, M.D.Founder and Chief...

Home NewsArbor Vita in the NewsPress Area About UsContact UsTechnologyPublicationsManagementPolicies ProductsDiagnostics OncoE6 Cervical Test A/H5N1 Flu Test Careers NewsIn the NewsPress Area Display #5101520253050100All U.S. Approves Rapid Avian Flu Test Spero News - April 13, 2009 Arbo...

Arbor Vita Corporation Announces Promising Clinical Study Results Demonstrating High Specificity of First Available Human Papillomavirus (HPV) E6 Protein Diagnostic Test for Cervical Cancer and Precancerous Lesions Large Study Evaluating Screening Tests Including HPV E6 Test for Cervical Cancer Scre...